New Test Shows Relapse Possibilities for Breast Cancer Patients

For the first time ever, the FDA approved a molecular test to help tell women just diagnosed with breast cancer if they will have to fight the disease again.

It is called mamma-print, and uses data from 70 different genes to see how aggressive a tumor is.

A computer program uses this information to predict whether a patient has a low or high risk for a cancer relapse in the next five of 10 years.

Now the test does give some false positives and negatives.

Still, FDA experts say the information mamma-print gives doctors is a lot better than having no information in predicting a patient's future health.

WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email:
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 5599391 -
Gray Television, Inc.